A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: In vitro release, permeation and mechanical properties

Journal of Controlled Release

Volumn 118, Issue 3, 2007, Pages 318-324

  Guo, Qinghai ^a   Guo, Shengrong ^a   Wang, Zhongmin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

5 fluorouracil; Esophageal mucosal permeation; Ethylene vinyl acetate; In vitro release; Mechanical properties; Stent coatings

Indexed keywords

COATINGS; COPOLYMERS; PH EFFECTS; TENSILE STRENGTH;

BUFFER SOLUTION; DRUG MOLECULES; ESOPHAGEAL MUCOSA; ESOPHAGEAL MUCOSAL PERMEATION; STENT COATINGS; TEAR STRENGTH;

ENDOTHELIAL CELLS;

ETHYLENE VINYL ACETATE COPOLYMER; FLUOROURACIL; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; ESOPHAGUS CANCER; MATERIAL COATING; MOLECULAR DYNAMICS; NONHUMAN; PH; PRIORITY JOURNAL; STENT; YOUNG MODULUS;

ANIMALS; BIOMECHANICS; DRUG DELIVERY SYSTEMS; ESOPHAGUS; FLUOROURACIL; PERMEABILITY; POLYVINYLS; STENTS; SWINE;

EID: 33947311527     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.12.030     Document Type: Article

References (31)

1. Thompson W.M. Esophageal carcinoma. Abdom. Imaging 22 (1997) 138-142
2. Levine M.S., and Halvorsen R.A. Carcinoma of the esophagus. In: Gore R.M., and Levine M.S. (Eds). Textbook of Gastrointestinal Radiology (2000), WB Saunders, Philadelphia 403-433
3. Unger E.C., Coia L., Gatenby R., Kessler H., Hartz W., Clair M., and Broder G. CT staging of esophageal carcinoma in patients treated by primary radiation therapy and chemotherapy. J. Comput. Assist. Tomogr. 16 (1992) 235-239
4. Xing D.Y., Tan W., and Lin D.X. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population. Oncol. Rep. 10 (2003) 1615-1623
5. Muller J.M., Erasmi H., Stelzner M., Zieren U., and Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br. J. Surg. 77 (1990) 845-857
6. Knyrim K., Wagner H.J., Bethge N., Keymling M., and Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N. Engl. J. Med. 329 (1993) 1302-1307
7. Sarper A., Oz N., Cihangir C., Demircan A., and Isin E. The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur. J. Cardio-Thorac. Surg. 23 (2003) 794-798
8. Johnson E., Enden T., Noreng H.J., Holck-Steen A., Gjerlaug B.E., Morken T., Johannessen H.O., and Drolsum A. Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand. J. Gastroenterol. 41 (2006) 252-256
9. Saxon R.R., Morrison K.E., Lakin P.C., Petersen B.D., Barton R.E., Katon R.M., and Keller F.S. Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. Radiology 202 (1997) 349-354
10. Watkinson A.F., Ellul J., Entwisle K., Mason R.C., and Adam A. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 195 (1995) 821-827
11. Shields S.J. Esophageal self-expandable metallic stents. Gastrointest. Endosc. 45 (1997) 439-442
12. Rozanes I., Poyanli A., and Acunas B. Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center's experience with four different stents. Eur. J. Radiol. 43 (2002) 196-203
13. Ell C., Hochberger J., May A., Fleig W., and Hahn E. Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: preliminary clinical experiences with Wallstents. Am. J. Gastroenterol. 89 (1994) 1496-1500
14. Hagiwara A., Takahashi T., Kitamura K., Sakakura C., Shoubayashi S., Osaki K., Iwamoto A., Lee M., and Fujita K. Endoscopic local injection of a new drug-delivery format of peplomycin for superficial esophageal cancer: a pilot study. Gastroenterology 104 (1993) 1037-1043
15. Nagano H., Machida Y., Iwata M., Imada T., Noguchi Y., Matsumoto A., and Nagai T. Preparation of magnetic granules containing bleomycin and its evaluation using model esophageal cancer. Int. J. Pharm. 147 (1997) 119-125
16. Batchelor H. Bioadhesive dosage forms for esophageal drug delivery. Pharm. Res. 2 22 (2005) 175-181
17. Hunter W.L., Burt H.M., and Machan L. Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents. Adv. Drug Deliv. Rev. 26 (1997) 199-207
18. Oettle H., Arnold D., Kern M., Hoepffner N., Settmacher U., Neuhaus P., and Riess H. Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer. Anticancer Drugs 13 (2002) 833-838
19. Ciftci K., Hincal A.A., Kas H.S., Ercan T.M., Sungur A., Guven O., and Ruacan S. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(l-lactic acid) microspheres. Pharm. Dev. Technol. 2 2 (1997) 151-160
20. Ajani J.A. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus. Chest 113 (1998) 112S-119S
21. Brierley J., Wong C.S., Cummings B., Catton P., Ringash J., Catton C., McLean M., Keane T., and Panzarella T. Squamous cell carcinoma of the oesophagus treated with radiation and 5-fluorouracil, with and without mitomycin C. Clin. Oncol. 3 (2001) 157-163
22. Xing D., Tan W., and Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population. Oncol. Rep. 10 (2003) 1615-1623
23. Grem J.L., and Chabner B.A. Cancer Chemotherapy: Principles and Practise (1990), J.B. Lippincott Company, Philadelphia
24. Koole L.H., Kruft M.A., Aldenhoff Y.B., van't Oost N.E., van Kroonenburgh M.J., and van der Veen F.H. Sustained local drug delivery from a radiopaque implanted reservoir. Nat. Biotechnol. 16 (1998) 172-176
25. Langer R., Brem H., and Tapper D. Biocompatibility of polymeric delivery systems for macromolecules. J. Biomed. Mater. Res. 15 2 (1981) 267-277
26. Sawyer P.N., Page M., Rudewald B., Lagergren H., Baselius L., McCool C., Halperin W., and Srinivasan S. Characteristics of the human heart: design requirements for replacement. Trans. Am. Soc. Artif. Intern. Organs 17 (1971) 470-473
27. Costantini L.C., Kleppner S.R., Donough J.M., Azar M.R., and Patel R. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism. Int. J. Pharm. 283 (2004) 35-44
28. Kalachandar S., Dongming L., and Offenbacher S. Controlled drug release for oral condition by a novel device based on ethylene vinyl acetate (EVA) copolymer. J. Mater. Sci., Mater. Med. 13 (2002) 53-58
29. Shin S.C., and Lee H.J. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix. Eur. J. Pharm. Biopharm. 54 (2002) 325-328
30. Siegel R.A. A Laplace transform technique for calculating diffusion time lags. J. Membr. Sci. 26 (1986) 251-262
31. Zhang H., and Robinson J.R. In vitro methods for measuring permeability of the oral mucosa. In: Rathbone M.J. (Ed). Oral Mucosal Drug Delivery (1996), Marcel Dekker, New York 90-93